Gates Package — page 863

dential and may contain sensitive information. It 2cipient. If you have received this e-mail in error other storage devices. The National Institute of for any statements made that are the sender's representatives. = < || _ || -- AM ; Support from NHLBI, NHGRI, and NIGMS. Also support from BMGF. Cool (oe) IHLB!) (] i >; NIAID) [E] ae Ge té«@W will likely discuss is the Are there any new »f this partnership. From: "Fauci, Anthony (NIH/NIAID) [E]" @niaid.nih.gov> To: "Collins, Francis (NIH/NHGRI) [E]" @nih.gov> Subject: RE: Seeing Bill Gates tomorrow Date: Tue, 27 Sep 2022 10:27:15 -0400 Importance: Normal See note from Carl Dieffenbach regarding NIAID activities with BMGF. Thanks, Tony Anthony S. Fauci, MD Director National Institute of Allergy and Infectious Diseases Building 31, Room 7A-03 31 Center Drive, MSC 2520 National Institutes of Health Bethesda, MD 20892-2520 Phone: FAX: E-mail: @niaid.nih.gov The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's own and not expressly made on behalf of the NIAID by one of its representatives. From: Collins, Francis (NIH/NHGRI) [E] @nih.gov> Sent: Tuesday, September 27, 2022 6:58 AM To: Gibbons, Gary (NIH/NHLBI) [E] @nih.gov>; Panepinto, Julie (NIH/NHLBI) [E] @nih.gov>; Dieffenbach, Carl (NIH/NIAID) [E] @niaid.nih.gov>; Fauci, Anthony (NIH/NIAID) [E] @niaid.nih.gov> Cc: Tabak, Lawrence (NIH/OD) [E] @nih.gov>; Schwetz, Tara (NIH/OD) [E] @nih.gov> Subject: RE: Seeing Bill Gates tomorrow P.S. I did see the recent JCI Insight paper that shows impressive results for in vivo gene editing of the fetal globin promoter in the mouse model of sickle cell disease. Cites support from NHLBI, NHGRI, and NIGMS. Also support from BMGF. Cool stuff. See attached. From: Collins, Francis (NIH/NHGRI) [E] Sent: Tuesday, September 27, 2022 6:48 AM To: Gibbons, Gary (NIH/NHLBI) [E] @nih.gov>; Panepinto, Julie (NIH/NHLBI) [E] @nih.gov>; Dieffenbach, Carl (NIH/NIAID) [E] @niaid.nih.gov>; Fauci, Anthony (NIH/NIAID) [E] @niaid.nih.gov> Cc: Tabak, Lawrence (NIH/OD) [E] @nih.gov>; Schwetz, Tara (NIH/OD) [E] @nih.gov> Subject: Seeing Bill Gates tomorrow Hi all, Bill Gates is at the White House tomorrow and asked to see me at 9 AM. Among the topics we will likely discuss is the HIV-SCD joint NIH-BMGF effort to develop cures that will be applicable in low income settings. Are there any new developments since the Sunnylands meeting back in May? Bill will likely ask about the future of this partnership.